DA-302168S Tablets

· Chendu DIAO Pharmaceutical Group CO., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-302168S Tablets, covering 2025-04-16 to 2025-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects [Phase 2]